logo
Products
Services
Resources
Selection Guides
About
APC/XFD750 Anti-human CD25 Antibody
HI25a
HI25a is an anti-human monoclonal antibody that is specific for the CD25 antigen. CD25 (sometimes called IL2RA) is a 55 kD transmembrane protein that is found on the surface of cells such as T cells, macrophages, B cells and NK cells. In certain organisms, CD25 is involved in the positive regulation of activated T cell proliferation, is a negative regulator of T cell proliferation and plays a role in the upregulation of T cell differentiation. Additionally, it is a component of important cellular pathways, for example, the cytokine-mediated signaling pathway, interleukin-2-mediated signaling pathway and Notch signaling pathway. From a research standpoint, it is of biological interest due to its association with key macromolecules/ligands like IL-2. CD25 is a very popular antibody target, with over 40000 publications in the last decade. CD25 has a variety of applications in immunology research, frequently serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to APC/XFD750 (ex/em = 756/785 nm). XFD750 is manufactured by AAT Bioquest, and it has a chemical structure similar to that of Alexa Fluor® 750 (Alexa Fluor® is the trademark of Thermo Fisher).
product image
CatalogSize
Price
Quantity
102501E025 tests
Price
102501E1100 tests
Price
102501E2500 tests
Price
 
Antibody properties

Other namesIL-2Rα, p55, TAC antigen
CloneHI25a
HostMouse
IsotypeIgG1
ReactivityHuman
Spectral properties

Extinction coefficient (cm -1 M -1)
700000
Excitation (nm)651
Emission (nm)785
Usage and storage

Intended useResearch Use Only (RUO)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on July 29, 2026